Finch raises £43m to advance microbiome-based therapies for recurrent CDI, Autism and other disease areas

Image: Finch raises £43m to advance microbiome-based therapies for recurrent CDI, Autism and other disease areas. Photo: courtesy of rawpixel from Pixabay.